The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi, J Kim… - Biomaterials, 2021 - Elsevier
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi… - Biomaterials, 2021 - pure.ewha.ac.kr
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon… - …, 2021 - scholarworks.bwise.kr
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis.

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi… - Biomaterials, 2021 - europepmc.org
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi… - Biomaterials, 2021 - pure.korea.ac.kr
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon… - …, 2021 - scholar.korea.ac.kr
Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

[引用][C] The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal …

J Kim, MK Shim, YJ Cho, S Jeon, Y Moon, J Choi, J Kim… - 2021